DrugPatentWatch Database Preview
Eywa Company Profile
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What is the competitive landscape for EYWA, and what generic and branded alternatives to EYWA drugs are available?
EYWA has five approved drugs.
Summary for Eywa
| US Patents: | 0 |
| Tradenames: | 4 |
| Ingredients: | 4 |
| NDAs: | 5 |
Drugs and US Patents for Eywa
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eywa Pharma | BACLOFEN | baclofen | TABLET;ORAL | 211555-001 | Feb 1, 2019 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Eywa Pharma | ALOSETRON HYDROCHLORIDE | alosetron hydrochloride | TABLET;ORAL | 211621-001 | Sep 16, 2019 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Eywa | OXYCODONE HYDROCHLORIDE | oxycodone hydrochloride | SOLUTION;ORAL | 209897-001 | Sep 6, 2017 | AA | RX | No | No | Start Trial | Start Trial | ||||
| Eywa | ACETAMINOPHEN AND CODEINE PHOSPHATE | acetaminophen; codeine phosphate | TABLET;ORAL | 211610-002 | Jun 27, 2019 | AA | RX | No | No | Start Trial | Start Trial | ||||
| Eywa Pharma | BACLOFEN | baclofen | TABLET;ORAL | 211555-002 | Feb 1, 2019 | AB | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
